October 1, 2024
Ocular Oncology Articles
October 1, 2024
Ocular Side Effects of Systemic Chemotherapy Agents
By Kapil Mishra, MD, Rolando Sceptre Ganasi, BS
September 1, 2024
Retinal Toxicity of Immunotherapy Drugs
By William Wagner, MD, Saam Mojtahed, MD, Arun D. Singh, MD
September 1, 2024
Upfront: How Far We've Come
By Peter K. Kaiser, MD
September 1, 2024
Choosing Treatment for Primary Vitreoretinal Lymphoma
By Elaine Binkley, MD, Farzad Jamshidi, MD, PhD
September 1, 2024
Intravitreal Chemotherapy for Retinoblastoma
By Vishal R. Raval, MD, Vidhi Bajpai, MS, Arun D. Singh, MD
September 1, 2024
Current Trials in Uveal Melanoma
By Yehonatan Weinberger, MD, Arun D. Singh, MD
September 1, 2024
New Drug Therapies for Benign Retinal Tumors
By Mary E. Aronow, MD
February 1, 2023
SUBSPECIALTY NEWS: Methotrexate for vitreoretinal lymphoma, drugs for retinitis pigmentosa, AI technology in retina, and more.
By Rochelle Nataloni, contributing writer
August 1, 2022
Light-activated Suprachoroidal Therapy for the First-line Treatment of Indeterminate Lesions and Small Choroidal Melanoma
By Buse Guneri Beser, MD, FEBO, FICO, Hakan Demirci, MD
April 1, 2022
SUBSPECIALTY NEWS: FDA approves uveal melanoma treatment, sepofarsen fails to meet endpoints, and more.
By Rochelle Nataloni, contributing writer
March 1, 2022
De Novo Choroidal Melanocytic Tumor
By Austen N. Knapp, MD, Guneet S. Sodhi, MD, Arun D. Singh, MD
January 1, 2022
Applications of Widefield Imaging in Ocular Oncology
By Janani Singaravelu, MD, Alexander Melendez, MD, Jacquelyn Wrenn, MSN, APRN-CNP , et al.